Back to Trades
Roberts Zachary
President and CEOCIK 0001851044
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Roberts Zachary, President and CEO, has filed 3 SEC reports (2026), all concentrated in Allogene Therapeutics, Inc. (ALLO), totaling $2.5M in disclosed volume. Weighing $0 bought versus $104.2K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jul 6 | ALLO Allogene Therapeutics, Inc. | Roberts Zachary | President and CEO | Award | $1.0M |
| Feb 4 | ALLO Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R&D | Sell | $63.2K |
| Jan 23 | ALLO Allogene Therapeutics, Inc. | Roberts Zachary | EVP of R&D | Sell | $41.0K |
3 filings